Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
10:05am, Thursday, 17'th Apr 2025
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Microfiltration Membranes Market Research - Global Forecast to 2029 with Merck, Sartorius, and Pall Leading
05:57am, Thursday, 17'th Apr 2025
Growth is driven by heightened demand for water and wastewater treatment due to water scarcity and stringent environmental regulations. Key industries like pharmaceuticals, food and beverages, and wat
Tariffs on generic drugs will cause companies to stop making them: Former FDA Commissioner Gottlieb
10:29am, Tuesday, 15'th Apr 2025
Dr. Scott Gottlieb, former FDA Commissioner, joins 'Squawk Box' to discuss current pharmaceutical imports under investigation, moving production for branded and generic drugs elsewhere, and much more.
The Tariff Game Just Changed: 7 Blue-Chip Bargains To Buy Now
09:09am, Tuesday, 15'th Apr 2025
Unprecedented Opportunities: Recent market panic has created deep discounts among world-class blue-chip companies trading at 52-week lows, offering up to 100% potential returns and secure yields appro
The Zacks Analyst Blog Merck and AbbVie
07:55am, Tuesday, 15'th Apr 2025
Merck and AbbVie are included in this Analyst Blog.
Merck (MRK) Stock Drops Despite Market Gains: Important Facts to Note
06:56pm, Monday, 14'th Apr 2025
The latest trading day saw Merck (MRK) settling at $79.17, representing a -0.01% change from its previous close.
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws,
NEW YORK , April 14, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK). Such investors are advise
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact Levi & Korsinsky
02:15pm, Monday, 14'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws,
Trump Says Pharmaceutical Tariffs Coming in Near Future
02:03pm, Monday, 14'th Apr 2025
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with repo
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE:MRK) between February 3, 2022 and
Trump says US pharma tariffs coming in not-too-distant future
12:26pm, Monday, 14'th Apr 2025
U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm
12:22pm, Monday, 14'th Apr 2025
LOS ANGELES--(BUSINESS WIRE)--MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm.
ABBV vs. MRK: Which Drug Giant is a Better Buy Now?
11:40am, Monday, 14'th Apr 2025
Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.
Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK
11:00am, Monday, 14'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws,
